Laboratory Innovation New

7.0 CME Credits

5 February 2020
Dubai World Trade Centre

09:30

Opening remarks

Dr P. K Menon, Director, Healthcare Management, CALM Worldwide FZE, Dubai, UAE

Supreet Singh Manchanda, Managing General Partner, Raiven Capital, San Francisco, California, USA

Session 1: Advancing administration & progressive process

Moderator: Dr P. K Menon, Director, Healthcare Management, CALM Worldwide FZE, Dubai, UAE

09:40

Riffs on FuturePath: The fall of paper, the rise of smarties, and the quest for selfies

Dr Eric Glassy, Board of Governor and Trustee, College of American Pathologists; Director of Pathology, Providence Little Company, Mary Medical Center; Past President, Digital Pathology Association, Los Angeles, California, USA

10:10

Innovations in redefining roles

Dr Maliha Hashmi, Executive Director, Health & Wellbeing, NEOM, Riyadh, KSA

10:40

Reinvigorating core lab services through reorganisation

Prof Dr Brad S Karon, Professor of Laboratory Medicine and Pathology, Chair, Division of Clinical Core
Laboratory Services, Mayo Clinic, Rochester, USA

11:10

 

Coffee break

Session 2: Cutting edge cellular developments I

ModeratorSupreet Singh Manchanda, Managing General Partner, Raiven Capital, San Francisco, California, USA

11:40

Advancing care through personalised diagnostics, phenomics and mass spectral pattern recognition

Prof Ricardo Pais, Data Scientist, MAPSciences, Lisbon, Portugal

12:10

‘Eye spy’: Stems cell potentials and pitfalls

Dr Igor Kozakromesh, Clinical Lead/Medical Director, Consultant  Ophthalmologist, Specialist in Vitreoretinal Surgery, Medical Retina and Uveitis, Moorfields Eye Hospital Centre, Abu Dhabi, UAE  

12:40

Lunch break and visit exhibition

Session 3: Cutting edge cellular developments

Moderator: Dr P. K Menon, Director, Healthcare Management, CALM Worldwide FZE, Dubai, UAE

13:40

Spotlights on CAR T Cell Therapy for Acute Lymphoblastic Leukemia

Dr Hisham Abdel-Azim, Director of BMT Fellowship Program, Attending Physician; Hematology, Oncology and Blood and Marrow Transplantation, Investigator, Hematology-Oncology, Associate Professor of Pediatrics, Keck School of Medicine of USC, Los Angeles, California, USA

14:10

CRISP R

Dr P. K Menon, Director, Healthcare Management, CALM Worldwide FZE, Dubai, UAE

 

14:40 Coffee break

Tailoring medication, ensuring the right dose to the right patient: The Role of CYP 450 Gene polymorphisms and ADE

Dr Nagib Yordi, Board Certified in Genetics and Genomics, American Board of Medical Genetics and Genomics, Consultant Orthopedic Surgery, Head
of Department of Orthopedics and Sports Medicine, Healthpoint, Abu Dhabi, UAE

Session 4: Trailblazing technology

ModeratorSupreet Singh Manchanda, Managing General Partner, Raiven Capital, San Francisco, California, USA

15:10

Syndromic testing, a new path for patient management and infection control

Dr Benoit Visseaux, Associate Professor, Virology, Bichat Claude Bernard Hospital, Paris, France 

15:40

Learnings from France: How the diagnostic industry is facing the future before it arrives

Dr Baher Al Hakim, CEO, Medicus AI, Vienna, Austria

16:10

AI and digital transformation in the laboratory

Dr Tarek El-Sawy, Adjunct Clinical Assistant Professor, Stanford University, California, USA 

16:40

3D design, VR and augmented reality advancing healthcare

Dr Ani Atanasova, CEO, pixelhunters, Dubai, UAE

17:10

Closing remarks

Dr P. K Menon, Director, Healthcare Management, CALM Worldwide FZE, Dubai, UAE

Supreet Singh Manchanda, Managing General Partner, Raiven Capital, San Francisco, California, USA

17:20

End of conference